uses cookies to improve your experience on the site. Your continued use of the site constitutes your acceptance of use of cookies on this site.
Find out more about how SonoWorld uses cookies. I’m OK with Cookies from SonoWorld - stop showing me this banner.
177,893 Registered Members as of 12/07/2019.
Daniela Bokor, MD
CEUS: A New Approach to Tumor Response to Treatment
Daniela Bokor, MD
01/03/2011 | Time : 25 min
About This Lecture:

Topics mentioned in this video : CEUS, Sensitive modality, Real time evaluation of normal/pathologic perfusion, Emerging clinical uses, Monitoring tumor response to anti-neoangiogenesis drugs, RECIST criteria are unsuitable, Are imaging modalities still useful to monitor tumor response?, Perfusion changes: the right clinical parameter?, CEUS validation protocols, Evaluation of tumor response to targeted therapy, Earlier indicator of tumor response targeted therapy vs. CT or MRI, Is CEUS reproducible, French multi-center study, Quantification approach, Quantitative parameters, Monitoring tumor response to targeted therapy, Metastatic renal cell carcinoma, Parametric imaging, Volume and perfusion changes, BR55 VEGF-R2 targeted bubbles, In vivo experiments, Canine prostate imaging, Conclusions

To view this lecture video, Login or register for a free membership below ↓
Already a Member? Login
Forgot username or password?
Register for Your FREE Membership Now!
Sign Up In Less Than One Minute
  • UNLOCK access to SonoWorld lectures, articles, cases, and more
  • Full Access Membership is FREE
  • You will have IMMEDIATE access on submitting the Membership form
  • JOIN the world's largest community of ultrasound professionals

* *
* *
* *
Review the SonoWorld Privacy Policy here.
Weekly Update Newsletter :
New Products and Services :
        Terms & Conditions         Privacy Policy

Keywords : angiogenesis, anti-angiogenesis therapy, anti-neoangiogenesis, CEUS, contrast enhanced ultrasound agents, gastrointestinal stromal tumor, GIST, liver lesions, liver metastases, liver mets, liver tumor, liver tumors, metastatic RCC, microbubbles, prostate contrast, RCC, RECIST, renal cell carcinoma, response evaluation criteria in solid tumors, tumor perfusion, tumor response

IE Browser Compatibility Close